Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium : self-reported occupational and household risk factors for seropositivity
Copyright © 2021 Elsevier Inc. All rights reserved..
This study aims to evaluate SARS-CoV-2 seroprevalence among health care workers (HCWs) and to assess self-reported risk factors for seropositivity. A total of 3255 HCWs were included and the overall seroprevalence was 7.8%. The likelihood of seropositivity was higher in participants reporting any COVID-19 symptoms within the last 4 months (OR 8.32, 95% CI 5.83-11.88, P < 0.001). Being a female HCW (OR 1.32, 95% CI 1.11-2.32, P < 0.01), having a cohabitant who was infected with SARS-CoV-2 (OR 2.55, 95% CI 1.78-3.66 P < 0.001) or a cohabitant who was a nursing home caregiver (OR 3.71, 95% CI 1.59-8.65, P = 0.002) were independently associated with an increased risk of seropositivity. Working in a COVID-19 unit (OR 1.64, 95% CI 1.21-2.23, P < 0.001) and being exposed to a SARS-CoV-2 infected co-worker (OR 1.30,95% CI 0.97-1.74, P = 0.016) resulted in higher seropositivity rate. Even if in-hospital exposure may play a significant role, increased infection risk is most likely attributable to household contact.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
---|---|
Enthalten in: |
Diagnostic microbiology and infectious disease - 100(2021), 4 vom: 15. Aug., Seite 115414 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Scohy, Anaïs [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 22.07.2021 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.diagmicrobio.2021.115414 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326306196 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326306196 | ||
003 | DE-627 | ||
005 | 20231225194316.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.diagmicrobio.2021.115414 |2 doi | |
028 | 5 | 2 | |a pubmed24n1087.xml |
035 | |a (DE-627)NLM326306196 | ||
035 | |a (NLM)34082266 | ||
035 | |a (PII)S0732-8893(21)00107-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Scohy, Anaïs |e verfasserin |4 aut | |
245 | 1 | 0 | |a Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium |b self-reported occupational and household risk factors for seropositivity |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.07.2021 | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
520 | |a This study aims to evaluate SARS-CoV-2 seroprevalence among health care workers (HCWs) and to assess self-reported risk factors for seropositivity. A total of 3255 HCWs were included and the overall seroprevalence was 7.8%. The likelihood of seropositivity was higher in participants reporting any COVID-19 symptoms within the last 4 months (OR 8.32, 95% CI 5.83-11.88, P < 0.001). Being a female HCW (OR 1.32, 95% CI 1.11-2.32, P < 0.01), having a cohabitant who was infected with SARS-CoV-2 (OR 2.55, 95% CI 1.78-3.66 P < 0.001) or a cohabitant who was a nursing home caregiver (OR 3.71, 95% CI 1.59-8.65, P = 0.002) were independently associated with an increased risk of seropositivity. Working in a COVID-19 unit (OR 1.64, 95% CI 1.21-2.23, P < 0.001) and being exposed to a SARS-CoV-2 infected co-worker (OR 1.30,95% CI 0.97-1.74, P = 0.016) resulted in higher seropositivity rate. Even if in-hospital exposure may play a significant role, increased infection risk is most likely attributable to household contact | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a HCW | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a household contact | |
650 | 4 | |a risk factors | |
650 | 4 | |a seroprevalence | |
700 | 1 | |a Gruson, Damien |e verfasserin |4 aut | |
700 | 1 | |a Simon, Anne |e verfasserin |4 aut | |
700 | 1 | |a Kabamba-Mukadi, Benoît |e verfasserin |4 aut | |
700 | 1 | |a De Greef, Julien |e verfasserin |4 aut | |
700 | 1 | |a Belkhir, Leïla |e verfasserin |4 aut | |
700 | 1 | |a Rodriguez-Villalobos, Hector |e verfasserin |4 aut | |
700 | 1 | |a Robert, Annie |e verfasserin |4 aut | |
700 | 1 | |a Yombi, Jean Cyr |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostic microbiology and infectious disease |d 1986 |g 100(2021), 4 vom: 15. Aug., Seite 115414 |w (DE-627)NLM01262845X |x 1879-0070 |7 nnns |
773 | 1 | 8 | |g volume:100 |g year:2021 |g number:4 |g day:15 |g month:08 |g pages:115414 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diagmicrobio.2021.115414 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 100 |j 2021 |e 4 |b 15 |c 08 |h 115414 |